Delivery Order SPE2DB22D1017-SPE2DB25FF9RQ

Award Date 4/8/25
Potential Completion Date 4/9/25
Potential Value $36K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of the HIV medication Biktarvy 50-200-25 mg tablet. The $26,557.84 firm fixed-price delivery order has a completion date of July 24, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support military...
This is a contract award to AmerisourceBergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor, by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $37,411 firm-fixed-price delivery order is for the supply of the HIV medication Biktarvy 50-200-25 mg tablets. The contract has an ultimate completion date of September 30, 2024. AmerisourceBergen holds a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,815.46 firm-fixed-price delivery order contract is for the supply of the HIV medication Biktarvy, with a period of performance through May 14, 2025. The contract is not set aside and was awarded as part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the HIV medication Biktarvy 50-200-25 mg tablets. The award, valued at $31,523.82, is a firm fixed-price delivery order placed by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of December 5, 2024 and was awarded on December 4, 2024. There is no set-aside designation indicated for this contract. Amerisourcebergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $57,385.59 firm fixed-price delivery order is for the supply of the HIV medication Biktarvy, with an ultimate completion date of January 18, 2024. This contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award, valued at $17,986.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Biktarvy 50-200-25 mg tablets, a brand-name HIV medication. This is a Firm Fixed Price delivery order contract with a period of performance through May 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,625.39, is a Firm Fixed Price Delivery Order for the provision of the drug Biktarvy, a medication used to treat HIV. The contract has an ultimate completion date of December 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $5,934.84 firm fixed-price delivery order is for the supply of the HIV medication Biktarvy 50-200-25 mg tablets. The contract has an ultimate completion date of July 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $109,586.33 firm fixed-price contract is for the supply of the HIV medication Biktarvy 50-200-25 mg tablets. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,326.01 delivery order contract, awarded by the Defense Logistics Agency (DLA), is for the supply of the HIV medication BIKTARVY 50-200-25 MG TABLET. The contract has a firm fixed price and runs through February 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF9RQ
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $36,218.78 firm fixed-price delivery order contract is for the supply of the HIV medication Biktarvy 50-200-25 mg tablets. The contract has an ultimate completion date of April 9, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 7/8/25, 2:30 PM